These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 4560750)

  • 1. The role of thymus-dependent immunity in Mycoplasma pulmonis infections of mice.
    Denny FW; Taylor-Robinson D; Allison AC
    J Med Microbiol; 1972 Aug; 5(3):327-36. PubMed ID: 4560750
    [No Abstract]   [Full Text] [Related]  

  • 2. The part played by cell-mediated immunity in mycoplasma respiratory infections.
    Taylor G; Taylor-Robinson D
    Dev Biol Stand; 1975; 28():195-210. PubMed ID: 1079193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Murine respiratory mycoplasmosis: a model to study effects of oxidants.
    Davis JK; Davidson M; Schoeb TR
    Res Rep Health Eff Inst; 1991 Dec; (47):1-29; discussion 31-43. PubMed ID: 1838926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction in the severity of Mycoplasma pneumoniae-induced pneumonia in hamsters by immunosuppressive treatment with antithymocyte sera.
    Taylor G; Taylor-Robinson D; Fernald GW
    J Med Microbiol; 1974 Aug; 7(3):343-8. PubMed ID: 4547395
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of immunosuppression on arthritis in mice induced by Mycoplasma pulmonis.
    Taylor G; Taylor-Robinson D; Slavin G
    Ann Rheum Dis; 1974 Jul; 33(4):376-84. PubMed ID: 4547195
    [No Abstract]   [Full Text] [Related]  

  • 6. Protection of mice against Mycoplasma pulmonis infection using purified mouse immunoglobulins: comparison between protective effect and biological properties of immunoglobulin classes.
    Taylor G; Howard CJ
    Immunology; 1981 Jul; 43(3):519-25. PubMed ID: 7251063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of active and passive immunization on Mycoplasma pulmonis-induced pneumonia in mice.
    Taylor G; Taylor-Robinson D
    Immunology; 1976 May; 30(5):611-8. PubMed ID: 1278933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on the effect of a thymic humoral factor on differentiation of thymus-derived lymphocytes.
    Lonai P; Mogilner B; Rotter V; Trainin N
    Eur J Immunol; 1973 Jan; 3(1):21-6. PubMed ID: 4146225
    [No Abstract]   [Full Text] [Related]  

  • 9. Pathogenesis of mycoplasmal pneumonia in swine.
    Livingston CW; Stair EL; Underdahl NR; Mebus CA
    Am J Vet Res; 1972 Nov; 33(11):2249-58. PubMed ID: 4562966
    [No Abstract]   [Full Text] [Related]  

  • 10. Protection by natural infection and vaccination against respiratory diseases caused by mycoplasmas.
    Whittlestone P
    Dev Biol Stand; 1975; 28():571-85. PubMed ID: 805075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secondary intratracheal infection of mice with Mycoplasma pulmonis generates IgG1 memory B cells.
    Rose FV; Cebra JJ
    Isr J Med Sci; 1987 May; 23(5):490-5. PubMed ID: 3499421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cultural and serological studies in experimentally induced pulmonary infection of hamsters with mycoplasma pneumoniae, mycoplasma salivarium and mycoplasma pulmonis.
    Sethi KK; Teschner M
    Z Immunitatsforsch Allerg Klin Immunol; 1970 Aug; 140(2):122-36. PubMed ID: 4248061
    [No Abstract]   [Full Text] [Related]  

  • 13. Variation in the virulence of strains of Mycoplasma pulmonis related to susceptibility to killing by macrophages in vivo.
    Howard CJ; Taylor G
    J Gen Microbiol; 1979 Oct; 114(2):289-94. PubMed ID: 232125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Indicators of humoral immunity to M. pneumoniae in healthy children and in children with respiratory tract infections].
    Korzhenkova MP; Vorotyntseva NV; Lozovskaia LS; Mirishli AD; Rybakova II
    Vopr Okhr Materin Det; 1974 Nov; 19(11):16-21. PubMed ID: 4612965
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunosuppressive chemotherapy and malignancy.
    Schwartz RS
    Transplant Proc; 1974 Dec; 6(4 Suppl 1):45-8. PubMed ID: 4612903
    [No Abstract]   [Full Text] [Related]  

  • 16. Differential susceptibility to Mycoplasma pulmonis intranasal infection in X-linked immunodeficient (xid), severe combined immunodeficient (scid), and immunocompetent mice.
    Sandstedt K; Berglöf A; Feinstein R; Bölske G; Evengård B; Smith CI
    Clin Exp Immunol; 1997 Jun; 108(3):490-6. PubMed ID: 9182897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of Mycoplasma pulmonis with mouse peritoneal macrophages and polymorphonuclear leucocytes.
    Taylor G; Howard CJ
    J Med Microbiol; 1980 Feb; 13(1):19-30. PubMed ID: 7359575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of pneumonia induced in mice with Mycoplasma pulmonis on resistance to subsequent bacterial infection and the effect of a respiratory infection with Sendai virus on the resistance of mice to Mycoplasma pulmonis.
    Howard CJ; Stott EJ; Taylor G
    J Gen Microbiol; 1978 Nov; 109(1):79-87. PubMed ID: 215702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary clearance of Mycoplasma pulmonis in C57BL/6N and C3H/HeN mice.
    Parker RF; Davis JK; Blalock DK; Thorp RB; Simecka JW; Cassell GH
    Infect Immun; 1987 Nov; 55(11):2631-5. PubMed ID: 3666955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of upper and lower respiratory tract immunity in resistance to Mycoplasma respiratory disease.
    Hodge LM; Simecka JW
    J Infect Dis; 2002 Jul; 186(2):290-4. PubMed ID: 12134269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.